Pomanda estimates the enterprise value of WELLCOME TRUST INVESTMENTS 2 UNLIMITED at £29.8m based on a Turnover of £26.5m and 1.12x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of WELLCOME TRUST INVESTMENTS 2 UNLIMITED at £195.8m based on an EBITDA of £26.4m and a 7.4x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of WELLCOME TRUST INVESTMENTS 2 UNLIMITED at £1.9b based on Net Assets of £986.6m and 1.96x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Wellcome Trust Investments 2 UnlimitedOverview
Wellcome Trust Investments 2 Unlimited is a live company located in london, NW1 2BE with a Companies House number of 06576220. It operates in the other service activities n.e.c. sector, SIC Code 96090. Founded in April 2008, it's largest shareholder is
the wellcome trust limited
with a 100% stake. Wellcome Trust Investments 2 Unlimited is a established,
large sized company, Pomanda has estimated its turnover at
£26.5m with
high
growth in recent years.
Wellcome Trust Investments 2 Unlimited Health Check
Pomanda's financial health check has awarded Wellcome Trust Investments 2 Unlimited a 4.5 rating. We use a traffic light system to show it exceeds the industry average on 5 measures and has 0 areas for improvement. Company Health Check FAQs
Health Rating4.5out of 5
5 Strong
2 Regular
0 Weak
Size
annual sales of £26.5m, make it larger than the average company (£922k)
£26.5m - Wellcome Trust Investments 2 Unlimited
£922k - Industry AVG
Growth
3 year (CAGR) sales growth of 30%, show it is growing at a faster rate (6.5%)
30% - Wellcome Trust Investments 2 Unlimited
6.5% - Industry AVG
Production
with a gross margin of 41.5%, this company has a comparable cost of product (41.5%)
41.5% - Wellcome Trust Investments 2 Unlimited
41.5% - Industry AVG
Profitability
an operating margin of 99.8% make it more profitable than the average company (6.5%)
99.8% - Wellcome Trust Investments 2 Unlimited
6.5% - Industry AVG
Employees
with 298 employees, this is above the industry average (14)
298 - Wellcome Trust Investments 2 Unlimited
14 - Industry AVG
Pay Structure
There is insufficient data available for this Key Performance Indicator!
- - Wellcome Trust Investments 2 Unlimited
- - Industry AVG
Efficiency
resulting in sales per employee of £88.9k, this is equally as efficient (£89k)
£88.9k - Wellcome Trust Investments 2 Unlimited
£89k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- - Wellcome Trust Investments 2 Unlimited
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- - Wellcome Trust Investments 2 Unlimited
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Wellcome Trust Investments 2 Unlimited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Wellcome Trust Investments 2 Unlimited
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 5.5%, this is a lower level of debt than the average (45.2%)
5.5% - Wellcome Trust Investments 2 Unlimited
45.2% - Industry AVG
WELLCOME TRUST INVESTMENTS 2 UNLIMITED financials
EXPORT
Wellcome Trust Investments 2 Unlimited's latest turnover from September 2023 is £26.5 million and the company has net assets of £986.6 million. According to their latest financial statements, we estimate that Wellcome Trust Investments 2 Unlimited has 298 employees and maintains cash reserves of 0 as reported in the balance sheet.
Data source:Companies House, Pomanda Estimates
Sep 2023
Sep 2022
Sep 2021
Sep 2020
Sep 2019
Sep 2018
Sep 2017
Sep 2016
Sep 2015
Sep 2014
Sep 2013
Sep 2012
Sep 2011
Sep 2010
Sep 2009
Turnover
26,496,394
13,062,137
11,072,656
12,182,880
10,786,585
569,067
747,305
252,560
265,022
820,913
259,164
1,037
Other Income Or Grants
Cost Of Sales
15,500,804
7,820,848
6,690,437
7,413,925
6,536,503
345,065
441,476
148,166
158,783
496,790
148,434
588
Gross Profit
10,995,590
5,241,289
4,382,219
4,768,955
4,250,082
224,002
305,829
104,394
106,239
324,123
110,730
448
Admin Expenses
-15,451,320
-7,692,358
-6,626,875
-7,379,089
-6,477,246
-457,387
-388,704
-65,332
-17,880
-336,026
122,631
9,551
-32,773
65,635
6,951
Operating Profit
26,446,910
12,933,647
11,009,094
12,148,044
10,727,328
681,389
694,533
169,726
124,119
660,149
-122,631
-9,551
143,503
-65,187
-6,951
Interest Payable
Interest Receivable
Pre-Tax Profit
91,138,000
-144,566,876
104,942,322
38,014,670
40,064,944
28,481,281
-2,173,841
-26,797,318
-69,626,767
-153,263,508
-19,122,410
-26,914,766
-14,157,231
-8,184,554
-6,951
Tax
-10,864,994
39,723,207
-20,849,172
-8,886,111
626,439
-3,793,469
1,515,396
9,746,906
11,287,262
Profit After Tax
80,273,006
-104,843,669
84,093,150
29,128,559
40,691,383
24,687,813
-658,445
-17,050,412
-58,339,505
-153,263,508
-19,122,410
-26,914,766
-14,157,231
-8,184,554
-6,951
Dividends Paid
Retained Profit
80,273,006
-104,843,669
84,093,150
29,128,559
40,691,383
24,687,813
-658,445
-17,050,412
-58,339,505
-153,263,508
-19,122,410
-26,914,766
-14,157,231
-8,184,554
-6,951
Employee Costs
25,843
102,411
24,688
Number Of Employees
298
160
151
165
143
8
11
4
4
11
1
1
4
1
EBITDA*
26,446,910
12,933,647
11,009,094
12,148,044
10,727,328
681,389
694,533
169,726
124,119
660,149
-122,631
-9,551
143,503
-65,187
-6,951
* Earnings Before Interest, Tax, Depreciation and Amortisation
Sep 2023
Sep 2022
Sep 2021
Sep 2020
Sep 2019
Sep 2018
Sep 2017
Sep 2016
Sep 2015
Sep 2014
Sep 2013
Sep 2012
Sep 2011
Sep 2010
Sep 2009
Tangible Assets
Intangible Assets
Investments & Other
639,874,953
595,866,362
863,728,386
774,744,896
840,335,993
319,134,256
286,601,371
234,183,611
424,351,204
423,286,956
937,697,367
630,719,946
614,129,799
411,286,490
92,267,102
Debtors (Due After 1 year)
Total Fixed Assets
639,874,953
595,866,362
863,728,386
774,744,896
840,335,993
319,134,256
286,601,371
234,183,611
424,351,204
423,286,956
937,697,367
630,719,946
614,129,799
411,286,490
92,267,102
Stock & work in progress
Trade Debtors
1,909,086
4,216,731
Group Debtors
401,875,613
354,785,344
395,709,280
250,608,880
89,898,035
44,625,844
39,681,624
142,308,414
53,779,635
599,082,741
144,445,125
94,902,333
55,560,331
22,609,739
Misc Debtors
2,257,564
2,300,323
2,544,984
41,486,229
36,273
18,673,535
Cash
20
20
17
18
19
misc current assets
total current assets
404,133,177
357,085,668
398,254,264
252,517,967
94,114,767
44,625,844
39,681,625
142,308,415
53,779,635
599,082,761
144,445,145
136,388,580
55,560,349
22,646,032
18,673,535
total assets
1,044,008,130
952,952,031
1,261,982,650
1,027,262,862
934,450,759
363,760,100
326,282,996
376,492,025
478,130,839
1,022,369,717
1,082,142,512
767,108,526
669,690,148
433,932,522
110,940,637
Bank overdraft
Bank loan
Trade Creditors
Group/Directors Accounts
33,393,858
22,451,653
102,191,301
4,038,183
183,324
other short term finances
hp & lease commitments
other current liabilities
32,123
114,024
56,288
41,072
32,216
75,624
209,984
170,750
64,153,143
125,499,635
23,008,360
14,192,864
15,345,300
107,108
6,951
total current liabilities
33,425,982
22,565,678
102,247,590
41,072
32,217
75,625
209,985
170,751
64,153,144
125,499,636
23,008,360
14,192,865
15,345,300
4,145,291
190,275
loans
hp & lease commitments
Accruals and Deferred Income
other liabilities
provisions
23,949,103
13,084,108
55,834,430
30,802,015
21,915,905
23,509,849
18,978,777
20,598,843
33,322,854
total long term liabilities
23,949,103
13,084,109
55,834,431
30,802,016
21,915,905
23,509,849
18,978,778
20,598,844
33,322,855
total liabilities
57,375,085
35,649,786
158,082,020
30,843,088
21,948,122
23,585,474
19,188,762
20,769,594
97,475,999
125,499,636
23,008,360
14,192,865
15,345,300
4,145,291
190,275
net assets
986,633,045
917,302,244
1,103,900,630
996,419,774
912,502,637
340,174,626
307,094,234
355,722,431
380,654,840
896,870,082
1,059,134,152
752,915,661
654,344,848
429,787,231
110,750,362
total shareholders funds
986,633,045
917,302,244
1,103,900,630
996,419,774
912,502,637
340,174,626
307,094,234
355,722,431
380,654,840
896,870,082
1,059,134,152
752,915,661
654,344,848
429,787,231
110,750,362
Sep 2023
Sep 2022
Sep 2021
Sep 2020
Sep 2019
Sep 2018
Sep 2017
Sep 2016
Sep 2015
Sep 2014
Sep 2013
Sep 2012
Sep 2011
Sep 2010
Sep 2009
Operating Activities
Operating Profit
26,446,910
12,933,647
11,009,094
12,148,044
10,727,328
681,389
694,533
169,726
124,119
660,149
-122,631
-9,551
143,503
-65,187
-6,951
Depreciation
Amortisation
Tax
-10,864,994
39,723,207
-20,849,172
-8,886,111
626,439
-3,793,469
1,515,396
9,746,906
11,287,262
Stock
Debtors
47,047,509
-41,168,596
145,736,298
158,403,200
49,488,922
4,944,220
-102,626,790
88,528,779
-545,303,106
454,637,616
8,056,563
80,828,231
32,914,318
3,972,478
18,673,535
Creditors
Accruals and Deferred Income
-81,901
57,736
15,216
8,856
-43,408
-134,360
39,234
-63,982,393
-61,346,492
102,491,275
8,815,496
-1,152,436
15,238,192
100,157
6,951
Deferred Taxes & Provisions
10,864,995
-42,750,322
25,032,415
8,886,110
-1,593,944
4,531,072
-1,620,066
-12,724,011
33,322,854
Cash flow from operations
-20,682,499
51,132,864
-130,528,745
-146,246,301
-39,772,507
-3,659,588
103,255,887
-155,318,551
528,690,849
-351,486,192
636,302
-81,990,218
-17,532,623
-3,937,508
-18,673,535
Investing Activities
capital expenditure
Change in Investments
44,008,590
-267,862,024
88,983,490
-65,591,097
521,201,737
32,532,885
52,417,761
-190,167,593
1,064,248
-514,410,411
306,977,421
16,590,148
202,843,309
319,019,388
92,267,102
cash flow from investments
-44,008,590
267,862,024
-88,983,490
65,591,097
-521,201,737
-32,532,885
-52,417,761
190,167,593
-1,064,248
514,410,411
-306,977,421
-16,590,148
-202,843,309
-319,019,388
-92,267,102
Financing Activities
Bank loans
Group/Directors Accounts
10,942,205
-79,739,648
102,191,301
-4,038,183
3,854,859
183,324
Other Short Term Loans
Long term loans
Hire Purchase and Lease Commitments
other long term liabilities
share issue
-10,942,205
-81,754,717
23,387,706
54,788,578
531,636,628
8,392,580
-47,969,752
-7,881,997
-457,875,736
-9,000,563
325,340,901
125,485,580
238,714,848
327,221,423
110,757,313
interest
cash flow from financing
-161,494,365
125,579,007
54,788,578
531,636,628
8,392,580
-47,969,752
-7,881,997
-457,875,736
-9,000,563
325,340,901
125,485,580
234,676,665
331,076,282
110,940,637
cash and cash equivalents
cash
-20
3
-1
-1
19
overdraft
change in cash
-20
3
-1
-1
19
wellcome trust investments 2 unlimited Credit Report and Business Information
Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for wellcome trust investments 2 unlimited. Get real-time insights into wellcome trust investments 2 unlimited's credit score, group structure and payment trends.
Perform a competitor analysis for wellcome trust investments 2 unlimited by selecting its closest rivals, whether from the OTHER SERVICE ACTIVITIES sector, other large companies, companies in NW1 area or any other competitors across 12 key performance metrics.
wellcome trust investments 2 unlimited Ownership
WELLCOME TRUST INVESTMENTS 2 UNLIMITED group structure
Wellcome Trust Investments 2 Unlimited has no subsidiary companies.
The sole shareholder of Wellcome Trust Investments 2 Unlimited is The Wellcome Trust Limited.
the wellcome trust limited
100%
wellcome trust investments 2 unlimited directors
Wellcome Trust Investments 2 Unlimited currently has 5 directors.
The longest serving directors include
Mr Nicholas Moakes (Apr 2008) and
Ms Elaina Elzinga (Jan 2018).
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to wellcome trust investments 2 unlimited.
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for WELLCOME TRUST INVESTMENTS 2 UNLIMITED. This can take several minutes, an email will notify you when this has completed.
wellcome trust investments 2 unlimitedCompanies House Filings - See Documents
